Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatic
ischemia
was induced by clamping the hepatic artery, portal vein, and bile duct. After 15 min of
ischemia
, the hepatic glutathione (GSH) content rapidly decreased. On the other hand, after the start of reperfusion, the hepatic GSH levels promptly increased and reached a peak at about 1 h, and thereafter decreased to a minimum level by 2 h. Under such conditions, we examined the changes in the
methionine adenosyltransferase
(
MAT
) activity in the liver. Though the time course of
MAT
activity was somewhat delayed compared with that of the hepatic GSH levels, both patterns were substantially similar during
ischemia
-reperfusion. In contrast to the changes in the
MAT
activity during
ischemia
-reperfusion, the levels of
MAT
protein were unchanged during these periods. When endogenous antioxidant coenzyme Q(10) (CoQ(10)) was administered to rats prior to
ischemia
, both the reduction in the
MAT
activity and hepatic GSH levels induced by
ischemia
-reperfusion were protected. Our findings suggest that CoQ(10) may posttranslationally regulate the
MAT
activity via the changes in the GSH level in the liver.
...
PMID:Regulation of methionine adenosyltransferase activity by the glutathione level in rat liver during ischemia-reperfusion. 1055 30